Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support
Status:
Completed
Trial end date:
2019-11-21
Target enrollment:
Participant gender:
Summary
Part A:once weekly dosing for 4 weeks in patients with short bowel syndrome who require total
parenteral nutrition; patients will complete period 1 and after a 6-10 week wash-out, they
will enter period 2 (active treatment and placebo); Part B: treatment period 3, is an open
label extension to part A and starts after a washout of 6-10 weeks after the last dose in
treatment period 2. patients are dosed once weekly for 4 weeks.